Search

everythinglearnresearchcommunity

for

Search:↓

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Hair follicle culture helps develop new treatments for hair loss.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Probe detects finasteride with high selectivity and low detection limit.

Both Platelet-Rich Plasma and Minoxidil foam increase hair count in women with hair loss, but Minoxidil is more effective. However, women were more satisfied with Platelet-Rich Plasma treatment.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Oral minoxidil effectively treats hair loss, with women needing lower doses (0.25 to 2.5 mg daily) and men needing higher doses (1.25 to 5 mg daily).

Anabolic steroid users may face higher risk of severe COVID-19.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Vesicular carriers like liposomes may improve cosmetic skin treatment delivery and effectiveness but need more human research.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Delayed ejaculation is a complex issue caused by psychological, biological, and lifestyle factors, requiring a holistic treatment approach.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The gel with special fat-loaded particles from rice bran could be an effective skin treatment for hair loss.

17α-Estradiol solution safely improves hair density and thickness in female pattern hair loss.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Men with male pattern baldness have a higher risk of certain skin cancers, especially on the scalp.

Methyl vanillate spray increases hair count and hair mass in women with hair loss.